Skip to main content
logo
bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.990
-0.040 (-1.32%)
Oct 30, 2026, 9:32 AM EDT - Market open

bioAffinity Technologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
45141413-
Market Cap Growth
-65.68%-62.63%1.49%4.34%--
Enterprise Value
3-215111-
Last Close Price
3.0317.70409.50661.73720.00-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.660.861.525.522788.11-
PB Ratio
0.360.735.452.881.21-
P/TBV Ratio
2.321.0333.575.341.21-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.49-1.624.40147.51-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.380.160.580.330.02-0.97
Net Debt / Equity Ratio
-0.26-0.730.15-0.26-1.01-0.85
Net Debt / EBITDA Ratio
0.080.53-0.050.162.79-4.54
Net Debt / FCF Ratio
0.090.56-0.050.212.60-4.88
Asset Turnover
0.950.711.270.250.00-
Inventory Turnover
61.08104.17259.63144.93--
Quick Ratio
1.242.410.721.6210.030.10
Current Ratio
1.442.600.871.7710.510.11
Return on Equity (ROE)
-1860.15%-301.83%-242.44%-99.84%--
Return on Assets (ROA)
-125.11%-75.63%-75.95%-48.85%-36.77%-172.53%
Return on Capital Employed (ROCE)
-250.70%-131.30%-262.70%-133.50%-36.30%19.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1996.49%-281.29%-63.74%-56.80%-60.89%-
FCF Yield
-297.39%-177.14%-51.78%-43.37%-32.04%-
Buyback Yield / Dilution
-578.55%-325.84%-38.61%---
SEC Filings: 10-K · 10-Q